Device Trial Radar · NCT04248283
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
Last checked: Nov 20, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
167
Planned (sponsor's estimate)
Start
Jan 26, 2021
Primary completion
May 31, 2027
Study completion May 31, 2032
Sponsor
- Lead sponsor
- UromedicaNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 30, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective, single arm, non-randomized, multicenter, prospective case-series trial. The purpose of this trial is to demonstrate the safety and effectiveness of using the Adjustable Continence Therapy (ACT) to provide a clinically relevant improvement in stress urinary incontinence.
Conditions
- Urinary Incontinence
- Urinary Incontinence,Stress
Interventions
Adjustable Continence Therapy for Women (ACT)Device
Two ACT devices are implanted in each patient. The devices are intended for implantation in the paraurethral space, with the balloons located on each side of the urethra near the bladder neck. The ports are placed subcutaneously in the labia majora. The balloons are filled after implantation with an isotonic solution via needle injection into the port. The ACT implant can be placed using local, spinal or general anesthesia with the surgical instruments (provided separately).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Provocative pad weightTime frame: 12 months
Locations
8 sites in 2 countries. Site status is shown where the registry gives one.
University of Colorado
Denver, Colorado · Recruiting
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.